You are here

COVID-19

Roche culls 2 COVID-19 drug hopefuls amid Q1 clear-out

Roche culls 2 COVID-19 drug hopefuls amid Q1 clear-out

Fierce Biotech

Flag link:

Johnson & Johnson to resume Covid-19 vaccine roll-out in Europe after EMA review

Johnson & Johnson to resume Covid-19 vaccine roll-out in Europe after EMA review

Pharmaceutical Business Review

Flag link:

Will Regeneron's COVID Cocktail Win Be Short-Lived?

Will Regeneron's COVID Cocktail Win Be Short-Lived?

Motley Fool

Flag link:

U.S. CDC expands COVID-19 vaccine eligibility to 16 and older

U.S. CDC expands COVID-19 vaccine eligibility to 16 and older

Reuters

Flag link:

Large clinical trial to study repurposed drugs to treat COVID-19 symptoms

Large clinical trial to study repurposed drugs to treat COVID-19 symptoms

NIH

clinical trials

drug repurposing

Flag link:

The next 2 months in biotech and pharma will be busy. Here's what to watch.

The next 2 months in biotech and pharma will be busy. Here's what to watch.

BioPharma Dive

Vertex Pharmaceuticals

Sarepta Therapeutics

Flag link:

Abbott Profits Triple As Over-the-counter Covid-19 Tests Hit Drugstore Shelves

Abbott Profits Triple As Over-the-counter Covid-19 Tests Hit Drugstore Shelves

Forbes

Flag link:

A top analyst sees Pfizer and Moderna seizing a $38B prize as safety frets sideline global vaccine players

A top analyst sees Pfizer and Moderna seizing a $38B prize as safety frets sideline global vaccine players

Endpoints

Moderna Therapeutics

Flag link:

How Johnson & Johnson Beat Expectations in Q1

How Johnson & Johnson Beat Expectations in Q1

Motley Fool

Flag link:

PPD-backed siteless trial specialist Medable reels in $78M as the pandemic continues to push its biz forward

PPD-backed siteless trial specialist Medable reels in $78M as the pandemic continues to push its biz forward

Fierce Biotech

decentralized clinical trials

clinical trials

Flag link:

EMA to add safety warning to J&J Covid-19 vaccine over rare blood clots

EMA to add safety warning to J&J Covid-19 vaccine over rare blood clots

Endpoints

Flag link:

Half of US adults have received at least one COVID-19 vaccine dose

Half of US adults have received at least one COVID-19 vaccine dose

Beckers Hospital Review

Flag link:

Serum Institute nears $400M grant to boost AstraZeneca COVID shot production—just as material shortages mount

Serum Institute nears $400M grant to boost AstraZeneca COVID shot production—just as material shortages mount

Fierce Pharma

Serum Institute

Flag link:

Fauci Says J&J Vaccine Likely to Resume by Friday

Fauci Says J&J Vaccine Likely to Resume by Friday

BioSpace

Flag link:

The Moderna CEO's Bold Statement That May Mean Bad News for Novavax

The Moderna CEO's Bold Statement That May Mean Bad News for Novavax

Motley Fool

Moderna Therapeutics

Stephane Bancel

Flag link:

Q&A with Acting FDA Commissioner Janet Woodcock on the Future of the FDA

Q&A with Acting FDA Commissioner Janet Woodcock on the Future of the FDA

BioSpace

Flag link:

FDA orders shutdown at Emergent's troubled plant 2 weeks after handing J&J the keys

FDA orders shutdown at Emergent's troubled plant 2 weeks after handing J&J the keys

Fierce Pharma

Emergent BioSolutions

drug manufacturing

Flag link:

Adagio raises a monster $336M round for bespoke COVID-19 drug battle

Adagio raises a monster $336M round for bespoke COVID-19 drug battle

Fierce Biotech

Adagio Therapeutics

Flag link:

South African variant may 'break through' Pfizer vaccine protection, but vaccine highly effective, Israeli study says

South African variant may 'break through' Pfizer vaccine protection, but vaccine highly effective, Israeli study says

Yahoo/Reuters

COVID-19 variants

Flag link:

Moderna cuts COVID-19 vaccine deliveries to Canada, U.K. amid European supply struggles

Moderna cuts COVID-19 vaccine deliveries to Canada, U.K. amid European supply struggles

Fierce Pharma

Moderna Therapeutics

Flag link:

Pages